Situation: A mid-size pharmaceutical company unexpectedly obtained a marketed CNS drug and needed to understand the financial impact of various

Situation: A fully integrated pharmaceutical company developing a class of immuno-oncology therapies was in need of a deeper understanding of

Situation: A publicly traded Oncology company with 3 technology platforms and limited resources was in need of narrowing their focus. 

What Can China Teach Us About CAR T is the final installment of our CAR-T series and discusses how China

Situation: A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the

Situation: An innovative oncology diagnostics company retained Kineticos to assist in developing their pitch deck, as well as developing and

Situation: A drug delivery technology company identified an opportunity to generate additional revenue by acquiring products to further develop and

Situation: An emerging oncology diagnostics company was in need of a Business Development strategy and retained Kineticos to develop such

Situation: As a NASDAQ traded oncology biotechnology company was preparing to expand globally, they requested Kineticos conduct a gap assessment

Situation:  A multinational pharmaceutical company with broad manufacturing capabilities was considering horizontally expanding their portfolio to include biosimilars. Kineticos was